8-K/A

AMENDMENT NO. 1

Company: Ernexa Therapeutics Inc.
Filed: June 15, 2006
Period of Report: June 7, 2006
Accession Number: 0000902595-06-000043

View Document ↗ View on SEC.gov ↗